Rennova Health, Inc. (NASDAQ: RNVA), Florida-based provider
of technologies and services to the healthcare industry, has successfully faced
a number of industry-wide challenges in recent years due to the steadfast focus
on strict compliance by its executive team and the resulting potential that
approach offers toward expanding provider contracts. It’s an accomplishment
based upon a blend of industry knowledge and a sound approach to management and
finance.
Thomas Mika (Chairman) – With an MBA from Harvard and an
undergraduate degree in Microbiology, Mr. Mika has held a number of executive
positions in the healthcare and other technology industries, and has an
extensive background in building healthcare and software companies. He is
Chairman, President, and Acting CFO of healthcare data analytics company
CollabRx, which merged with Rennova in November 2015. Earlier he was President
and Chief Executive Officer of Tegal Corporation, becoming Chairman of the
Board the following year. At Tegal he had served as Executive Vice President,
Chief Financial Officer, and was on the Board of Directors, managing the activities
that led to the company’s IPO in 1995.
Seamus Lagan (President, Chief Executive Officer, Director)
– Mr. Lagan’s expertise includes over two decades in the restructuring,
development, and management of both public and private companies. His guidance
has been critical to the growth of Rennova Health, as well as to the company’s
achieving an impressive NASDAQ listing. Mr. Lagan was initially approached to
help in the development of new business opportunities for the company, and his
efforts have supported the structuring of the company’s business plan as well
as the securing of vital funding. Mr. Lagan has also served as the CEO of two
principal subsidiaries of Medytox Solutions.
Jason Adams (Chief Financial Officer) – Mr. Adams has held
senior financial executive positions with Alico and Source Interlink Companies,
and was the Chief Financial Officer of West Central Behavioral Health, a
provider of mental health services to communities in New Hampshire.
Sri Bharat Madireddy, PhD (COO of Medytox Diagnostics, CEO
of Rennova owned Laboratories) – Dr. Madireddy serves Rennova as Technical
Supervisor and Director LC-MSMS for Toxicology operations. He is Board
Certified in Clinical Chemistry by the American Association of Bioanalysts, and
has extensive experience in analytical chemistry and toxicology.
For more information, visit www.RennovaHealth.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment